Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis
Clinical trial NCT03768089 · COMPLETED
Trial details
- NCT number
- NCT03768089
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2019-05-03
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.